223 related articles for article (PubMed ID: 37644458)
41. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
[TBL] [Abstract][Full Text] [Related]
42. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y;
Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147
[TBL] [Abstract][Full Text] [Related]
43. Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study.
COVID-19 Omicron Delta study group
PLoS One; 2023; 18(4):e0282806. PubMed ID: 37104488
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study.
Krutikov M; Stirrup O; Nacer-Laidi H; Azmi B; Fuller C; Tut G; Palmer T; Shrotri M; Irwin-Singer A; Baynton V; Hayward A; Moss P; Copas A; Shallcross L;
Lancet Healthy Longev; 2022 May; 3(5):e347-e355. PubMed ID: 35531432
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
[TBL] [Abstract][Full Text] [Related]
46. Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
medRxiv; 2022 Feb; ():. PubMed ID: 35169811
[TBL] [Abstract][Full Text] [Related]
47. Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes.
Ambrose N; Amin A; Anderson B; Barrera-Oro J; Bertagnolli M; Campion F; Chow D; Danan R; D'Arinzo L; Drews A; Erlandson K; Fitzgerald K; Garcia M; Gaspar FW; Gong C; Hanna G; Jones S; Lopansri B; Musser J; O'Horo J; Piantadosi S; Pritt B; Razonable RR; Roberts S; Sandmeyer S; Stein D; Vahidy F; Webb B; Yttri J
JAMA Netw Open; 2023 Apr; 6(4):e239694. PubMed ID: 37093599
[TBL] [Abstract][Full Text] [Related]
48. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
[TBL] [Abstract][Full Text] [Related]
49. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.
Mediavilla JR; Lozy T; Lee A; Kim J; Kan VW; Titova E; Amin A; Zody MC; Corvelo A; Oschwald DM; Baldwin A; Fennessey S; Zuckerman JM; Kirn T; Chen L; Zhao Y; Chow KF; Maniatis T; Perlin DS; Kreiswirth BN
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632041
[TBL] [Abstract][Full Text] [Related]
50. Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases.
Harrigan SP; Wilton J; Chong M; Abdia Y; Velasquez Garcia H; Rose C; Taylor M; Mishra S; Sander B; Hoang L; Tyson J; Krajden M; Prystajecky N; Janjua NZ; Sbihi H
Clin Infect Dis; 2023 Feb; 76(3):e18-e25. PubMed ID: 36041009
[TBL] [Abstract][Full Text] [Related]
51. A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study.
Thi Hong Nguyen N; Ou TY; Huy LD; Shih CL; Chang YM; Phan TP; Huang CC
Front Public Health; 2023; 11():1145138. PubMed ID: 37333556
[TBL] [Abstract][Full Text] [Related]
52. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
53. Clinical and Biochemical Characteristics of COVID-19 Patients During the Delta-Omicron Wave with Risk Assessment of Adverse Outcomes.
Iqbal S; Khan S; Qureshi MA; Sayeed MA; Khan BA; Zaheer S; Faruqui H; Rajput AW
J Coll Physicians Surg Pak; 2023 Mar; 33(3):297-302. PubMed ID: 36945160
[TBL] [Abstract][Full Text] [Related]
54. Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations.
Gunadi ; Hakim MS; Wibawa H; Marcellus ; Trisnawati I; Supriyati E; Afiahayati ; Khair RE; Iskandar K; Siswanto ; Irene ; Anggorowati N; Daniwijaya EW; Nugrahaningsih DAA; Puspadewi Y; Simanjaya S; Puspitarani DA; Hanifin HF; Setiawan AA; Tania I; Amalia CS; Artayasa IPA; Rachman H; Mulyawan H; Ananda NR; Arguni E; Nuryastuti T; Wibawa T
Sci Rep; 2021 Nov; 11(1):21352. PubMed ID: 34725366
[TBL] [Abstract][Full Text] [Related]
55. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.
Bager P; Wohlfahrt J; Bhatt S; Stegger M; Legarth R; Møller CH; Skov RL; Valentiner-Branth P; Voldstedlund M; Fischer TK; Simonsen L; Kirkby NS; Thomsen MK; Spiess K; Marving E; Larsen NB; Lillebaek T; Ullum H; Mølbak K; Krause TG;
Lancet Infect Dis; 2022 Jul; 22(7):967-976. PubMed ID: 35468331
[TBL] [Abstract][Full Text] [Related]
56. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
[TBL] [Abstract][Full Text] [Related]
57. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.
Sadeghi F; Halaji M; Shirafkan H; Pournajaf A; Ghorbani H; Babazadeh S; Ezami N; Fallhpour K; Fakhraie F; Gorjinejad S; Amoli SS; Amiri FH; Baghershiroodi M; Ahmadnia Z; Salehi M; Tourani M; Jafarzadeh J; Tabari FS; Ahmadian SR; Mohammadi Abandansari R; Jafarian F; Rouhi S; Zabihollahi A; Mostafanezhad S; Saeedi F; Ebrahimian A; Deldar Z; Zavareh MSH; Bayani M; Broun MB; Shirzad M; Sabbaghi S; Mohammadi M; Rahmani R; Yahyapour Y
BMC Infect Dis; 2024 Jan; 24(1):55. PubMed ID: 38184533
[TBL] [Abstract][Full Text] [Related]
58. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome.
Robinson ML; Morris CP; Betz JF; Zhang Y; Bollinger R; Wang N; Thiemann DR; Fall A; Eldesouki RE; Norton JM; Gaston DC; Forman M; Luo CH; Zeger SL; Gupta A; Garibaldi BT; Mostafa HH
Clin Infect Dis; 2023 May; 76(9):1539-1549. PubMed ID: 36528815
[TBL] [Abstract][Full Text] [Related]
59. Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent.
Pascall DJ; Vink E; Blacow R; Bulteel N; Campbell A; Campbell R; Clifford S; Davis C; da Silva Filipe A; El Sakka N; Fjodorova L; Forrest R; Goldstein E; Gunson R; Haughney J; Holden MTG; Honour P; Hughes J; James E; Lewis T; MacLean O; McHugh M; Mollett G; Nyberg T; Onishi Y; Parcell B; Ray S; Robertson DL; Seaman SR; Shabaan S; Shepherd JG; Smollett K; Templeton K; Wastnedge E; Wilkie C; Williams T; ; Thomson EC
J Infect; 2023 Aug; 87(2):128-135. PubMed ID: 37270070
[TBL] [Abstract][Full Text] [Related]
60. Real-world effect of casirivimab and imdevimab cocktail in patients infected with SARS-CoV-2 delta and omicron variants.
Subhash Walinjkar R; Kumbhar M; Harihar Shinde R; Chaurasia E
J Infect Dev Ctries; 2023 Mar; 17(3):293-301. PubMed ID: 37023427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
